» Articles » PMID: 25639832

A Missense Mutation Underlies Defective SOCS4 Function in a Family with Autoimmunity

Overview
Journal J Intern Med
Specialty General Medicine
Date 2015 Feb 3
PMID 25639832
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to determine the genetic and immunological defects underlying familial manifestations of an autoimmune disorder.

Methods: Whole-exome sequencing was performed on the index patient with various manifestations of autoimmunity, including hypothyroidism, vitiligo and alopecia. Peripheral blood mononuclear cells and DNA of family members were used for functional and genetic testing of the candidate variants obtained by Sanger sequencing.

Results: Exome sequencing identified 233 rare, coding and nonsynonymous variants in the index patient; five were highly conserved and affect genes that have a possible role in autoimmunity. Only a heterozygous missense mutation in the suppressor of cytokine signalling 4 gene (SOCS4) cosegregated with the autoimmune disorder in the family. SOCS4 is a known inhibitor of epidermal growth factor (EGF) receptor signalling, and functional studies demonstrated specific upregulation of EGF-dependent immune stimulation in affected family members.

Conclusion: We present a family with an autoimmune disorder, probably resulting from dysregulated immune responses due to mutations in SOCS4.

Citing Articles

Unravelling the druggability and immunological roles of the SOCS-family proteins.

Lynch D, Forrester B, Webb T, Ciulli A Front Immunol. 2024; 15:1449397.

PMID: 39676878 PMC: 11638205. DOI: 10.3389/fimmu.2024.1449397.


Zebrafish Suppressor of Cytokine Signaling 4b (Socs4b) Is Dispensable for Development but May Regulate Epidermal Growth Factor Receptor Signaling.

Trengove M, Rasighaemi P, Liongue C, Ward A Biomolecules. 2024; 14(9).

PMID: 39334830 PMC: 11430285. DOI: 10.3390/biom14091063.


Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies.

Arts P, Simons A, AlZahrani M, Yilmaz E, Alidrissi E, van Aerde K Genome Med. 2019; 11(1):38.

PMID: 31203817 PMC: 6572765. DOI: 10.1186/s13073-019-0649-3.


Progressive multifocal leukoencephalopathy in an immunocompetent patient.

van der Kolk N, Arts P, van Uden I, Hoischen A, van de Veerdonk F, Netea M Ann Clin Transl Neurol. 2016; 3(3):226-32.

PMID: 27042682 PMC: 4774259. DOI: 10.1002/acn3.279.